Bisthianostat
倍赛诺他
Report date: 2022/05/12 11:14:01
NME
Base Information
Drug NameBisthianostat
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Puyi Chemical Co LtdShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of SciencesShanghai Puyi Chemical Co Ltd
Inactive CompaniesSorrento Pharmaceuticals (Shanghai) Co Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A